Pharmafile Logo
Pharmafocus logo
Advanced Search
celgene_building

NICE recommends Celgene’s Revlimid combo for follicular lymphoma

February 27, 2020
Sales and Marketing Cancer, Celgene, NICE, Revlimid, follicular lymphoma, pharma

NICE has chosen to recommend Celgene’s Revlimid (lenalidomide) for use on the NHS, it has emerged, alongside Genentech’s Rituxan (rituximab), …

News

Female participation up in 2019 US clinical trials, but minority representation down

February 27, 2020
Medical Communications, Research and Development FDA, clinical trials, pharma

The FDA’s Drugs Trials Snapshots 2019 report has been released, clarifying the demographic distribution of participants who were included in …

News
shutterstock_95714119

US Judge rules that a decade of unpublished trial results must be made public

February 27, 2020
Medical Communications, Research and Development FDA, US, clinical trials, pharma

A federal judge in New York’s Southern District has ruled that 10 years of unpublished clinical trial data must now …

News
shutterstock

First US coronavirus trial launched into Gilead’s remdesivir

February 26, 2020
Research and Development FDA, Gilead, US, coronavirus, pharma

The first US clinical trial investigating a treatment for the COVID-19 coronavirus has been launched by the US National Institute …

News
hqdefault

Takeda acquires PvP Biologics after successful Phase 1 study of Celiac Disease treatment

February 26, 2020
Research and Development Celiac, PvP, Takeda, phase 1, phase III

Takeda has acquired PvP Biologics following the conclusion of a Phase 1 study of the investigational medicine TAK-062 for the …

News

Global cases of coronavirus rise, as first US soldier in South Korea tests positive for the virus

February 26, 2020
Research and Development

The number of global cases of COVID-19 continues to rise as several nations work to contain outbreaks, in particular South …

News
nice_new_london_office_internal_3_web

NICE rejects Roche’s Polivy combo in relapsed or refractory diffuse large B-cell lymphoma

February 26, 2020
Manufacturing and Production, Research and Development, Sales and Marketing NHS, NICE, Polivy, Roche

It has been revealed that UK drug watchdog NICE has chosen to reject Roche’s Polivy (polatuzumab vedotin), used alongside rituximab …

News
36745826313_86e4ffa6ac_b

New Johnson & Johnson study aiming to add stroke detection to Apple Watch

February 26, 2020
Research and Development Apple, Janssen, Johnson & Johnson, apple watch, iphone, stroke

Johnson & Johnson announced that Janssen Pharmaceuticals will work in collaboration with Apple to explore apps for stroke detection. It …

News
scotland

Scotland’s life sciences sector on track to break $8 billion by 2025

February 25, 2020
Manufacturing and Production, Sales and Marketing Scotland, UK, life sciences, pharma

A new report from the Scottish Government has revealed that the country’s life sciences sector is on track to breeze …

News
peoples_assembly_20150620

Austerity policies blamed as English life expectancy stalls for first time in a century

February 25, 2020
Manufacturing and Production England, NHS England, UCL, austerity, life expectancy

A landmark report has shown that English life expectancy has stalled for the first time in a century, and reversed …

News

FDA greenlights first oral, daily, non-statin therapy for lowering LDL-Cholesterol

February 25, 2020
Manufacturing and Production, Sales and Marketing Esperion, FDA, Nexletol, pharma

Esperion’s ATP Citrase Lyase (ACL) inhibitor Nexletol (bempedoic acid) has secured approval from the FDA, it has emerged. It is …

News
homoopathie-globuli-naturopathy-naturopaths-homeopathy-beads-royalty-free-thumbnail

World’s second largest API company to be created by Sanofi

February 25, 2020
Manufacturing and Production API, APIs, China API, Coronavirus API, India API, Sanofi

Sanofi plans to create a new company in Europe dedicated to the production and marketing of active pharmaceutical ingredients (API). …

News
26682732344_ae569bf0e3_b

US domestic supply of 150 drugs under threat from coronavirus outbreak

February 25, 2020
Manufacturing and Production MERS, Sars, US, US Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus

Disruption to the US drug production pipeline from the coronavirus could hurt its domestic supply of 150 drugs. US senators …

News
160x100

2020 Veeva Unified Clinical Operations Survey

February 24, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, survey, veeva

Every year, Veeva asks clinical professionals to take part in the Veeva Unified Clinical Operations Survey to help the industry …

Feature
holly_springs_9frontflags

FDA approves first adjuvanted quadrivalent flu vaccine in over-65s

February 24, 2020
Sales and Marketing FDA, flu, influenza, pharma, seqirus

The FDA has just authorised its first adjuvanted quadrivalent influenza vaccine, it has been announced. Seqirus’ Fluad Quadrivalent (influenza vaccine, adjuvanted) …

News
shutterstock_212035546

Clover Biopharmaceuticals partners up with GSK to accelerate coronavirus vaccine development

February 24, 2020
Sales and Marketing China, Clover Biopharmaceuticals, GSK, coronavirus, pharma

Chinese biotech firm Clover Biopharmaceuticals has joined the race to develop interventions against the ongoing coronavirus outbreak with the announcement …

News
lilly_entrance_web

Eli Lilly’s Trulicity approved in US to reduce cardiovascular events in type 2 diabetes patients

February 24, 2020
Sales and Marketing Eli Lilly, Trulicity, cardiovascular disease, pharma

Eli Lilly’s Trulicity (duraglutide) has been awarded marketing authorisation from the FDA as a therapy to reduce major adverse cardiovascular …

News

Lundbeck’s Vyepti secures US approval for migraine prevention

February 24, 2020
Sales and Marketing FDA, Lundbeck, Vyepti, migraine, pharma

Lundbeck’s Vyepti (eptinezumab-jjmr) has secured approval from the FDA, it has emerged, for the prevention of migraine in adult patients. …

News
fdaoutsideweb

FDA approval for Baudax Bio’s non-opioid painkiller Anjeso

February 24, 2020
Sales and Marketing Anjeso, FDA, opioids, pharma

Baudax Bio has revealed the FDA approval of its non-opioid painkiller Anjeso (meloxicam injection) as a therapy for the management …

News
shutterstock_512649

Merck KGaA to flog Allergopharma business to Dermapharm

February 21, 2020
Medical Communications, Sales and Marketing Allergopharma, Dermapharm, Merck KGaA, pharma

German-based drugmaker Merck KGaA has confirmed its intention to divest its allergy business Allergopharma to Dermapharm, another German manufacturer of …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026